MicroRNAs regulate epithelial-mesenchymal transition of supraglottic laryngeal cancer.
- Author:
Jun TAI
1
;
Xiao XIAO
;
Zhi-gang HUANG
;
Zhen-kun YU
;
Xiao-hong CHEN
;
Wei-guo ZHOU
;
Xue-jun CHEN
;
Yuan-sheng RAO
;
Ju-gao FANG
;
Xin NI
Author Information
- Publication Type:Journal Article
- MeSH: Aged; Cadherins; Carcinoma, Squamous Cell; genetics; metabolism; Epithelial-Mesenchymal Transition; physiology; Gene Expression Profiling; Head and Neck Neoplasms; genetics; metabolism; Humans; Laryngeal Neoplasms; genetics; metabolism; Larynx; Larynx, Artificial; Lymph Nodes; Lymphatic Metastasis; genetics; MicroRNAs; metabolism; Phosphatidylinositol 3-Kinases; metabolism
- From: Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2013;48(6):499-503
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study microRNAs (miRNAs) expression profiles associated with epithelial-mesenchymal transition (EMT) in lymph node metastasis of supraglottic laryngeal squamous cell carcinomas(SGLSCC).
METHODSPrimary tumor tissue samples of 12 SGLSCC patients were collected, including 6 patients clinically diagnosed with lymph nodes metastasis (N(+)) and 6 patients with lymph nodes metastasis-free (N0), for miRNA microarray gene-expression profiling to identify the differences between N(+) and N0 groups. Differentially expressed miRNAs was verified using quantitative real-time PCR in 20 patients with N(+) and 20 patients with N0. Target genes for the miRNAs associated with EMT in SGLSCC metastasis were analyzed.
RESULTSTen miRNAs differentially expressed between N(+) group and N0 group were determined. Comparing with N0 group, nine miRNAs were over-expressed and one miRNA was expressed at lower level in N(+) group. The genes for miR-192, miR-143, miR-409 and miR-634 were predicted as target genes that could promote EMT of laryngeal cancer cells by targeted inhibiting Krüppel-like factor 17(KLF17), E-cadherin and phosphatidylinositol 3 kinase (PI3K).
CONCLUSIONSThe miRNAs over-expressed in group N(+) can be used to predict cervical lymph node metastasis in SGLSCC. The miRNAs as new markers could improve the diagnosis and treatment of SGLSCC.